<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
	<title>ThaiPR.NET</title>
	<atom:link href="https://www.thaipr.net/location/mountain-view-calif/feed" rel="self" type="application/rss+xml" />
	<link>https://www.thaipr.net/location/mountain-view-calif</link>
	<description>Press Release Distribution Center of Thailand</description>
	<lastBuildDate>Fri, 03 Apr 2026 17:33:14 +0700</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.1</generator>
	<item>
		<title><![CDATA[OpenLight Introduces 224G InP-based Modulator to Advance PIC Designs for Datacom Market]]></title>
		<link>https://www.thaipr.net/en/it_en/3310298</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 07 Mar 2023 08:50:30 +0700</pubDate>
				<category>it_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/it_en/3310298</guid>

					<description><![CDATA[<p>New Modulator Increases Speed and Scale to 224G/λ for Future High-Speed Applications OpenLight today announced that it developed and successfully demonstrated a 224G InP-based modulator available for Tower&#8217;s PH18DA platform. Measured as part of a fully operational photonic integrated circuit (PIC), OpenLight extended the speed of its PAM4 modulator and demonstrated a PAM4 224G eye. This new 224G [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/it_en/3310298">OpenLight Introduces 224G InP-based Modulator to Advance PIC Designs for Datacom Market</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[OpenLight Announces Availability of First Process Design Kit Sampler to Accelerate Component Testing]]></title>
		<link>https://www.thaipr.net/en/it_en/3309135</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Thu, 02 Mar 2023 09:05:20 +0700</pubDate>
				<category>it_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/it_en/3309135</guid>

					<description><![CDATA[<p>New Product Offers Lab-Testing Flexibility and Enhances PIC Design Accuracy to Accelerate Time to Market To enhance familiarity with process technologies and increase the accessibility of photonic integrated circuits (PICs), OpenLight today announced the general availability of its process design kit (PDK) Sampler. The PDK Sampler is a unique, die-level PIC which contains OpenLight&#8217;s standard PDK components, [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/it_en/3309135">OpenLight Announces Availability of First Process Design Kit Sampler to Accelerate Component Testing</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[The world&#8217;s oldest living lab rat points the way to rejuvenation]]></title>
		<link>https://www.thaipr.net/en/health_en/3299983</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Thu, 09 Feb 2023 08:00:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3299983</guid>

					<description><![CDATA[<p>&#8220;Sima&#8221;, a 47 months-old female rat, is being treated with E5, a treatment intended to recreate the circulatory environment of a young mammal; the maximum recorded lifespan for this species is 45.5 months. An experiment led by Dr. Harold Katcher, one of the discoverers of the first breast cancer gene, is giving humanity hope of fulfilling the [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3299983">The world&#8217;s oldest living lab rat points the way to rejuvenation</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[OpenLight Appoints Dr. Adam Carter as Chief Executive Officer]]></title>
		<link>https://www.thaipr.net/en/business_en/3292050</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Wed, 18 Jan 2023 09:06:54 +0700</pubDate>
				<category>business_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/business_en/3292050</guid>

					<description><![CDATA[<p>Industry Veteran to Lead Company&#8217;s Growth with Integrated Laser Open-Foundry Business OpenLight, the world&#8217;s first open silicon photonics technology with integrated lasers, today announced the appointment of Dr. Adam Carter as its Chief Executive Officer. Dr. Carter has over 25 years of experience in the semiconductor industry, including a variety of roles in Sales, Marketing [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/business_en/3292050">OpenLight Appoints Dr. Adam Carter as Chief Executive Officer</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[OpenLight Unveils First 800G DR8 Photonic Integrated Circuit Design to Advance Global Datacenter Interconnect Industry]]></title>
		<link>https://www.thaipr.net/en/it_en/3280854</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Thu, 15 Dec 2022 08:39:27 +0700</pubDate>
				<category>it_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/it_en/3280854</guid>

					<description><![CDATA[<p>Fully validated design provides customers with a shortcut to create 800G DR8 transceivers and accelerate customer time to market for data center applications Delivering new levels of performance and scalability to accelerate the design of photonic integrated circuits (PICs) for datacom applications, OpenLight today announced the availability of its first 800G DR8 PIC design targeted at datacenter [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/it_en/3280854">OpenLight Unveils First 800G DR8 Photonic Integrated Circuit Design to Advance Global Datacenter Interconnect Industry</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[OpenLight Announces Process Design Kit Availability with Industry&#8217;s First Unified Electronic and Photonic Design Platform]]></title>
		<link>https://www.thaipr.net/en/it_en/3271191</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Wed, 23 Nov 2022 08:45:00 +0700</pubDate>
				<category>it_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/it_en/3271191</guid>

					<description><![CDATA[<p>New Offering Enables Fast, Accurate and Reliable Photonic IC Designs with On-Chip Laser Technology To streamline the end-to-end design of photonic integrated circuits (PICs) and meet future demands of applications including datacom, telecom, LiDAR, healthcare, HPC, AI, and optical computing, OpenLight today announced the general availability of its process design kit (PDK). The OpenLight PDK is ready [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/it_en/3271191">OpenLight Announces Process Design Kit Availability with Industry&#8217;s First Unified Electronic and Photonic Design Platform</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Introducing Arta Finance: the digital family office for the world &#8211; using technology to unlock the financial superpowers of the ultra-wealthy]]></title>
		<link>https://www.thaipr.net/en/finance_en/3260754</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Thu, 03 Nov 2022 08:15:57 +0700</pubDate>
				<category>finance_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/finance_en/3260754</guid>

					<description><![CDATA[<p>Arta Finance has raised more than $90M from Sequoia Capital India, Ribbit Capital, Coatue Management and more than 140 angel investors to unlock the financial superpowers of the ultra-wealthy by making family office services available to everyone. Arta Finance, a Digital Family Office, unveiled its platform today, starting with accredited investors in the United States. [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/finance_en/3260754">Introducing Arta Finance: the digital family office for the world &#8211; using technology to unlock the financial superpowers of the ultra-wealthy</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Turn Biotechnologies launches eTurna™ delivery platform designed specifically to enable nucleic acid therapeutics]]></title>
		<link>https://www.thaipr.net/en/health_en/3238711</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Wed, 14 Sep 2022 08:05:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3238711</guid>

					<description><![CDATA[<p>The proprietary platform is versatile, equally effective with different cargoes, routes of administration Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced it has created a novel platform to safely and effectively deliver nucleic acid therapeutics – a major expansion of the company&#8217;s business. The eTurna Platform™ [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3238711">Turn Biotechnologies launches eTurna™ delivery platform designed specifically to enable nucleic acid therapeutics</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Prominent ophthalmologist will guide Turn Bio&#8217;s search for therapies to cure eye diseases]]></title>
		<link>https://www.thaipr.net/en/health_en/3228423</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 23 Aug 2022 08:15:14 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3228423</guid>

					<description><![CDATA[<p>Albert Wu, MD, PhD, a recognized advocate of using stem cell therapy to treat eye conditions, will advise company&#8217;s development of ocular tissue rejuvenation therapeutics Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that Albert Wu, MD, PhD, will oversee its development of ophthalmic therapeutic products as [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3228423">Prominent ophthalmologist will guide Turn Bio&#8217;s search for therapies to cure eye diseases</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Prominent Stanford University scientist and cellular reprogramming innovator will oversee all research for Turn Bio]]></title>
		<link>https://www.thaipr.net/en/health_en/3222199</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 09 Aug 2022 08:20:49 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3222199</guid>

					<description><![CDATA[<p>Vittorio Sebastiano, globally recognized for pioneering science, expands his role at company he co-founded as it moves closer to clinical research Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that co-founder Vittorio Sebastiano, PhD, will become its head of research. Sebastiano led development of the unique [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3222199">Prominent Stanford University scientist and cellular reprogramming innovator will oversee all research for Turn Bio</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[OpenLight Unveils Brand Identity and Technology Portfolio to Usher in World&#8217;s First Open Silicon Photonics Platform with Integrated Lasers]]></title>
		<link>https://www.thaipr.net/en/it_en/3198447</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 07 Jun 2022 08:05:31 +0700</pubDate>
				<category>it_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/it_en/3198447</guid>

					<description><![CDATA[<p>New Era of Laser Integration and Scalability Delivers Unparalleled Performance, Power Efficiency and Reliability Addressing the growing silicon photonics market requirements for improved performance, power efficiency and reliability, OpenLight, a newly launched company, today introduced the world&#8217;s first open silicon photonics platform with integrated lasers. OpenLight&#8217;s platform provides a new level of laser integration and [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/it_en/3198447">OpenLight Unveils Brand Identity and Technology Portfolio to Usher in World&#8217;s First Open Silicon Photonics Platform with Integrated Lasers</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program]]></title>
		<link>https://www.thaipr.net/en/health_en/3179572</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 12 Apr 2022 08:10:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3179572</guid>

					<description><![CDATA[<p>Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio&#8217;s preclinical advances in multiple therapeutic areas Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that it closed an oversubscribed fundraising round to support the next stage of [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3179572">Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Turn Biotechnologies completes latest round of funding]]></title>
		<link>https://www.thaipr.net/en/general_en/3050168</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Thu, 29 Apr 2021 08:00:00 +0700</pubDate>
				<category>general_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/general_en/3050168</guid>

					<description><![CDATA[<p>Silicon Valley investor Khosla Ventures joins esteemed group of global investors backing Turn Turn Biotechnologies, a company developing novel RNA medicines for untreatable age-related conditions, today announced that it has closed its latest round of funding. The company has the support of investors focused on identifying and backing enterprises that have the potential to change [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/general_en/3050168">Turn Biotechnologies completes latest round of funding</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
	</channel>
</rss>
